Novartis Announces Layoffs to Streamline US Operations
SOURCENews reportView the filing ↗
What we know
Location: United States.
Based on news reporting.
Summary
Novartis has announced layoffs affecting approximately 300 employees as part of its efforts to streamline operations in the United States. The decision comes amid ongoing restructuring initiatives aimed at enhancing efficiency and reducing costs. The layoffs are expected to take effect on October 1, 2023, as the company seeks to adapt to changing market conditions and improve its operational framework. This move reflects Novartis's commitment to maintaining competitiveness in the pharmaceutical industry while managing its workforce effectively.
LayoffTalk has tracked 24 layoff events at Novartis East Hanover since March 2025, including 234 jobs documented in official WARN filings, with 20 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Novartis East Hanover
Recent tracked events at this company.